Clinical consequences of ADRbeta2 polymorphisms. - Wikidata - awgldk - TriplyDB

Clinical consequences of ADRbeta2 polymorphisms.

Clinical consequences of ADRbeta2 polymorphisms.

http://www.wikidata.org/entity/Q37096063

about

Cysteinyl Leukotrienes Pathway Genes, Atopic Asthma and Drug Response: From Population Isolates to Large Genome-Wide Association Studies Genome-wide association analysis in asthma subjects identifies SPATS2L as a novel bronchodilator response gene Pharmacogenetics of chronic obstructive pulmonary disease: challenges and opportunities.Genetic polymorphisms and associated susceptibility to asthma.Beta 1- and beta 2-adrenoceptor polymorphisms and cardiovascular diseases.Beta-2-Adrenergic Receptor Methylation Influences Asthma Phenotype in The School Inner City Asthma Study.Very important pharmacogene summary ADRB2.Biochemical basis of asthma therapy.Clinical asthma phenotyping: A trial for bridging gaps in asthma management β2-Adrenergic receptor promoter haplotype influences the severity of acute viral respiratory tract infection during infancy: a prospective cohort study.A genome-wide analysis of the response to inhaled β2-agonists in chronic obstructive pulmonary disease.What have we learned from prospective cohort studies of asthma in children?Genetic association analysis of COPD candidate genes with bronchodilator responsiveness.Genetics of chronic obstructive pulmonary disease: a succinct review, future avenues and prospective clinical applications.Asthma: Gln27Glu and Arg16Gly polymorphisms of the beta2-adrenergic receptor gene as risk factors.β-2 adrenergic receptor gene methylation is associated with decreased asthma severity in inner-city schoolchildren: asthma and rhinitis.Pharmacogenetics and human genetic polymorphisms.SNPs in genes encoding G proteins in pharmacogenetics.Association between ß2-adrenergic receptor gene polymorphisms and adverse events of ritodrine in the treatment of preterm labor: a prospective observational study.

P2860

Q28067073-F6F955E3-0CA3-425E-A124-513C4751A3F7 Q28481005-79EB7F04-442C-4A85-9ECD-59656E285DD0 Q33706037-6DC5BB1C-5989-46DC-A06C-44BD6D8FB79E Q34342451-B2C4DA78-F19D-483E-8A9B-7D1F6E64AC8E Q34658477-5429E2E9-34B4-4BA6-BFBE-5195A7B2D08B Q34906177-FE2722B9-D24D-45BB-89FA-DD2A9B73C69B Q34994884-A059EF73-C748-44C7-BFB7-5285DCCD0D34 Q35312155-B1B36C44-BD7B-4D02-9920-8FE43914F02B Q35626634-E984621C-B074-4E13-A8AB-7F12F419CFA5 Q35775111-D7D79054-2301-498C-B9EA-4CD5F4F2A159 Q36844920-E682101E-19AB-4C1D-A71A-65E9D25202B7 Q37333398-E2101565-9283-48F2-918D-51D4CDAB2FDA Q37351330-9737442E-988E-4E01-A0FA-34F2100D83E8 Q37448915-763B8250-B0C8-44D5-B175-D8C98392EB06 Q37595504-3159EA05-85BC-4869-907B-DE680ADE5101 Q37706994-3AE68DF8-E087-4E35-B752-10CA4DE42CDC Q37772183-3912569C-DA78-460F-A44A-1EDA915BE1FC Q37880876-CD2FF114-2877-4ED8-A036-597C49B7FF39 Q46977246-89B78A3D-DB90-44F7-8E9F-01E77E76E709

P2860

Clinical consequences of ADRbeta2 polymorphisms.

http://www.wikidata.org/entity/Q37096063

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Clinical consequences of ADRbeta2 polymorphisms.

@en

Clinical consequences of ADRbeta2 polymorphisms.

@nl

type

label

Clinical consequences of ADRbeta2 polymorphisms.

@en

Clinical consequences of ADRbeta2 polymorphisms.

@nl

prefLabel

Clinical consequences of ADRbeta2 polymorphisms.

@en

Clinical consequences of ADRbeta2 polymorphisms.

@nl

P1433

Q37096063-205DE232-E2A5-4C84-B327-396C5F3CAC85

P1476

Q37096063-59436089-7625-4249-A798-A7C9710850A8

P2093

Q37096063-44CF9A83-5FF4-4C7A-87C7-1B1563FF2019

Q37096063-6B5F946B-3F82-4545-8829-B00A0FA9F290

P2860

Q37096063-087F24E9-3C13-4F8E-9E6A-D8FAF2FA59D6

Q37096063-0B7DD221-A71B-4F02-87E5-51B583913671

Q37096063-0EFE7513-ED66-45BF-96B1-42130310C28E

Q37096063-1A51B3D4-1967-461E-8AFD-7BD2F6185777

Q37096063-1D549C9B-D729-4D7F-93C1-3E75296E1D34

Q37096063-29B630E3-D676-4EF4-B0D0-0D027C5E614B

Q37096063-408AB890-0E30-49D1-973E-E9F2C3031423

Q37096063-431D1DF2-EFC4-4A7A-8D1E-D8A1C3270433

Q37096063-464F6B1C-1F98-4678-8FEA-A364B94035F7

Q37096063-494880E6-D864-49D6-AEC2-2B06FEE233BF

P304

Q37096063-C9828FF4-EF3A-4E7E-9DBB-3F9FAB6C9512

P31

Q37096063-455612FB-73AE-4A6B-A751-3452DC6424EF

P356

Q37096063-CACA57D4-6F6D-46A2-8A07-7E3B9EBDBF72

P433

Q37096063-082DDDB1-C136-46A6-87A5-DF36050343F9

P478

Q37096063-420C5A2B-6B7D-4FAC-BAB7-28EA553020F8

P50

Q37096063-DBBC0156-1A77-4131-8FEE-62A1C8608CB9

P577

Q37096063-645F31D4-DF7A-48EF-A8FB-26E0934FA041

P5875

Q37096063-3E682CC4-86D1-483B-8E26-C983A2A13705

P698

Q37096063-0CB7FDD3-73FC-4304-84A3-2A31FE1AD697

P356

14622416.9.3.349

P1433

Pharmacogenomics

P1476

Clinical consequences of ADRbeta2 polymorphisms.

@en

P2093

Gregory A Hawkins

http://www.w3.org/2001/XMLSchema#string

Scott T Weiss

http://www.w3.org/2001/XMLSchema#string

P2860

Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing

Genetic susceptibility to asthma--bronchial hyperresponsiveness coinherited with a major gene for atopy

Association of glutamine 27 polymorphism of beta 2 adrenoceptor with reported childhood asthma: population based study

The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma.

Genetic polymorphisms of the beta 2-adrenergic receptor in nocturnal and nonnocturnal asthma. Evidence that Gly16 correlates with the nocturnal phenotype

Lower bronchodilator responsiveness in Puerto Rican than in Mexican subjects with asthma.

Identification of novel polymorphisms within the promoter region of the human beta2 adrenergic receptor gene.

Asthma exacerbations during long term beta agonist use: influence of beta(2) adrenoceptor polymorphism.

The arginine-16 beta2-adrenoceptor polymorphism predisposes to bronchoprotective subsensitivity in patients treated with formoterol and salmeterol

Arginine-16 beta2 adrenoceptor genotype predisposes to exacerbations in young asthmatics taking regular salmeterol

P304

349-358

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/14622416.9.3.349

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Eugene R Bleecker

P577

2008-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5548472

http://www.w3.org/2001/XMLSchema#string

P698

18303970

http://www.w3.org/2001/XMLSchema#string